Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 26% ± 8% | |
| microglial cell | 7 studies | 25% ± 9% | |
| natural killer cell | 6 studies | 19% ± 3% | |
| fibroblast | 6 studies | 19% ± 3% | |
| adipocyte | 6 studies | 26% ± 4% | |
| astrocyte | 6 studies | 26% ± 9% | |
| epithelial cell | 5 studies | 33% ± 10% | |
| macrophage | 5 studies | 29% ± 6% | |
| oligodendrocyte | 5 studies | 24% ± 5% | |
| myeloid cell | 4 studies | 24% ± 4% | |
| ciliated cell | 4 studies | 24% ± 3% | |
| naive B cell | 4 studies | 17% ± 1% | |
| hepatocyte | 4 studies | 37% ± 20% | |
| oligodendrocyte precursor cell | 4 studies | 27% ± 8% | |
| endothelial cell of lymphatic vessel | 4 studies | 20% ± 2% | |
| smooth muscle cell | 4 studies | 18% ± 1% | |
| T cell | 3 studies | 16% ± 0% | |
| B cell | 3 studies | 28% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 2% | |
| mature NK T cell | 3 studies | 19% ± 3% | |
| cardiac muscle cell | 3 studies | 18% ± 2% | |
| lymphocyte | 3 studies | 25% ± 1% | |
| GABAergic neuron | 3 studies | 42% ± 3% | |
| glutamatergic neuron | 3 studies | 50% ± 2% | |
| dendritic cell | 3 studies | 28% ± 15% | |
| monocyte | 3 studies | 20% ± 2% | |
| basal cell | 3 studies | 25% ± 4% | |
| pericyte | 3 studies | 20% ± 4% | |
| neuron | 3 studies | 37% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2176.41 | 1444 / 1445 | 100% | 17.93 | 183 / 183 |
| lung | 100% | 2167.98 | 577 / 578 | 100% | 14.22 | 1155 / 1155 |
| prostate | 100% | 3294.02 | 245 / 245 | 100% | 21.13 | 501 / 502 |
| ovary | 100% | 3990.99 | 180 / 180 | 100% | 14.00 | 429 / 430 |
| breast | 100% | 2500.24 | 459 / 459 | 100% | 26.90 | 1113 / 1118 |
| brain | 99% | 1249.88 | 2624 / 2642 | 100% | 14.71 | 703 / 705 |
| thymus | 100% | 2604.40 | 653 / 653 | 99% | 14.27 | 599 / 605 |
| intestine | 100% | 2552.01 | 966 / 966 | 99% | 10.45 | 521 / 527 |
| uterus | 100% | 4313.91 | 170 / 170 | 98% | 15.81 | 451 / 459 |
| stomach | 100% | 1765.16 | 359 / 359 | 98% | 13.14 | 281 / 286 |
| pancreas | 100% | 1404.18 | 327 / 328 | 98% | 10.01 | 174 / 178 |
| bladder | 100% | 2753.38 | 21 / 21 | 97% | 10.27 | 488 / 504 |
| kidney | 100% | 1265.27 | 89 / 89 | 95% | 11.04 | 854 / 901 |
| adrenal gland | 100% | 1721.43 | 258 / 258 | 93% | 7.41 | 214 / 230 |
| skin | 100% | 2054.43 | 1808 / 1809 | 92% | 12.57 | 436 / 472 |
| liver | 100% | 1329.82 | 226 / 226 | 85% | 7.63 | 347 / 406 |
| adipose | 100% | 2668.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2325.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2464.93 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2516.46 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.84 | 45 / 45 |
| heart | 97% | 1380.14 | 832 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 10.39 | 26 / 29 |
| peripheral blood | 85% | 1230.24 | 787 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 69% | 5.92 | 55 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048599 | Biological process | oocyte development |
| GO_0009566 | Biological process | fertilization |
| GO_0035264 | Biological process | multicellular organism growth |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0009791 | Biological process | post-embryonic development |
| GO_0048872 | Biological process | homeostasis of number of cells |
| GO_0060746 | Biological process | parental behavior |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0001541 | Biological process | ovarian follicle development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005694 | Cellular component | chromosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0043035 | Molecular function | chromatin insulator sequence binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZFX |
| Protein name | Zinc finger protein ZFX isoform 4 Zinc finger X-chromosomal protein X-linked zinc finger protein isoform 5 Zinc finger protein X-linked ZFX protein Alternative protein ZFX Zinc finger protein ZFX X-linked zinc finger protein |
| Synonyms | |
| Description | FUNCTION: Probable transcriptional activator. |
| Accessions | Q8NHZ1 ENST00000304543.10 [P17010-1] Q8NHZ3 L8E7U7 B7ZKJ5 C9J682 Q8NHZ4 ENST00000539115.5 [P17010-2] Q8NHZ5 Q8NHZ2 ENST00000428571.5 Q8WWU0 ENST00000379177.5 [P17010-1] E9PEP7 ENST00000379188.7 [P17010-3] P17010 ENST00000338565.3 Q8WXB7 C9JGU9 Q8WXB9 ENST00000419690.5 Q9BYX9 Q8WXB8 |